Investigational cardiac myosin activator. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy25

Myocardium Myocytes, Cardiac Heart Sarcomeres Heart Ventricles Muscles Actin Cytoskeleton Myofibrils Cells, Cultured Gizzard Heart Atria Muscle, Smooth Muscle, Skeletal Myoblasts, Cardiac Cell Line Muscle Fibers, Skeletal Cytoskeleton Heart Conduction System Fetal Heart Fibroblasts Chick Embryo Muscle Fibers, Slow-Twitch Muscle Fibers, Fast-Twitch Muscle, Smooth, Vascular Aorta

Organisms20

Rabbits Chickens Rats, Inbred Lew Swine Mice, Transgenic Dogs Cattle Animals, Newborn Rats, Sprague-Dawley Mice, Knockout Mice, Inbred C57BL Enterovirus B, Human Rats, Wistar Dictyostelium Turkeys Mollusca Amoeba Mice, Inbred Strains Acanthamoeba Mice, Inbred BALB C

Diseases29

Myocarditis Cardiomyopathy, Hypertrophic Autoimmune Diseases Cardiomegaly Cardiomyopathy, Hypertrophic, Familial Arrhythmias, Cardiac Death, Sudden, Cardiac Cardiomyopathies Cardiomyopathy, Dilated Rheumatic Heart Disease Disease Models, Animal Heart Failure Cardiac Tamponade Heart Diseases Hyperthyroidism Myocardial Infarction Heart Arrest Hypothyroidism Coxsackievirus Infections Cardiac Output, Low Ventricular Remodeling Out-of-Hospital Cardiac Arrest Heart Defects, Congenital Fibrosis Myocardial Ischemia Ventricular Dysfunction, Left Heart Neoplasms Heart Injuries Hypertrophy, Left Ventricular

Chemicals and Drugs94

Myosins Cardiac Myosins Myosin Heavy Chains Myosin Subfragments Myosin Light Chains Myosin Type II Ventricular Myosins Myosin Type V Actins Actomyosin Myosin-Light-Chain Kinase Nonmuscle Myosin Type IIA Tissue Plasminogen Activator Myosin Type I Nonmuscle Myosin Type IIB Adenosine Triphosphatases Plasminogen Activator Inhibitor 1 Urokinase-Type Plasminogen Activator Carrier Proteins Peptide Fragments Ca(2+) Mg(2+)-ATPase Calcium Molecular Motor Proteins Protein Isoforms Smooth Muscle Myosins Adenosine Triphosphate Myosin Type III Tropomyosin Troponin I Troponin RNA, Messenger Heterocyclic Compounds with 4 or More Rings Skeletal Muscle Myosins Propylthiouracil Receptors, Urokinase Plasminogen Activator Adrenergic beta-2 Receptor Antagonists Plasminogen Activators Autoantibodies Myosin-Light-Chain Phosphatase G(M2) Activator Protein Recombinant Proteins Adenosine Diphosphate Isoenzymes Muscle Proteins Cyclic AMP-Dependent Protein Kinases Thyroxine Transcription Factors Plasminogen Activator Inhibitor 2 Magnesium Ethylmaleimide Plasminogen Inactivators Trans-Activators Cardiac Glycosides DNA-Binding Proteins Calmodulin Sphingolipid Activator Proteins rho-Associated Kinases DNA Primers Receptor Activator of Nuclear Factor-kappa B Troponin T Epitopes Recombinant Fusion Proteins Calmodulin-Binding Proteins Peptides Transcription Factor AP-1 Cardiotonic Agents Enzyme Inhibitors Antibodies, Monoclonal STAT3 Transcription Factor Plasminogen Fibrinolysin Protein Kinase C Protein Kinases Connectin Atrial Myosins Microfilament Proteins Cyanogen Bromide Myosin Type IV Biological Markers Azepines Isoproterenol Macromolecular Substances Calcium-Binding Proteins Cytokines RANK Ligand Protein-Serine-Threonine Kinases Phosphoprotein Phosphatases Atrial Natriuretic Factor Enzyme Activators Fibrinolytic Agents DNA Bacterial Outer Membrane Proteins Fibrin Troponin C

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Cardiac Output Cardiac Surgical Procedures Electrophoresis, Polyacrylamide Gel Disease Models, Animal Cardiac Pacing, Artificial Echocardiography Cardiac Catheterization Microscopy, Electron Blotting, Western Electrocardiography Cloning, Molecular Cardiac Imaging Techniques Heart Rate Models, Biological Heart Transplantation Blood Pressure Treatment Outcome Stroke Volume Transfection Heart Function Tests Cardiac Resynchronization Therapy Cardiopulmonary Resuscitation Polymerase Chain Reaction Microscopy, Fluorescence Immunohistochemistry Models, Cardiovascular Prospective Studies Reverse Transcriptase Polymerase Chain Reaction Fluorescent Antibody Technique Epitope Mapping Immunization Pedigree Cardiopulmonary Bypass Follow-Up Studies Risk Factors

Phenomena and Processes51

Cardiac Output Myocardial Contraction Amino Acid Sequence Phosphorylation Kinetics Base Sequence Protein Binding Mutation Time Factors Binding Sites Muscle Contraction Promoter Regions, Genetic Gene Expression Regulation Cross Reactions Ventricular Function, Left Signal Transduction Transcription, Genetic Gene Expression Enzyme Activation Molecular Mimicry Organ Specificity Protein Conformation Molecular Weight Autoimmunity Heart Rate Phenotype Hemodynamics Ventricular Remodeling Species Specificity Cardiac Volume Protein Structure, Tertiary Genes Regulatory Sequences, Nucleic Acid Dose-Response Relationship, Drug Blood Pressure Mutation, Missense Chemical Phenomena Aging Stroke Volume Transfection Point Mutation Cell Differentiation Hydrogen-Ion Concentration Muscle Development Cell Movement Ventricular Function Transcriptional Activation Isometric Contraction Sequence Homology, Amino Acid Gene Expression Regulation, Developmental Cytoplasmic Streaming

Disciplines and Occupations3

Chemistry Immunohistochemistry Cardiac Electrophysiology

Information Science3

Molecular Sequence Data Amino Acid Sequence Base Sequence

Health Care6

Treatment Outcome Cardiac Care Facilities Prospective Studies Immunization Follow-Up Studies Risk Factors

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Myosins Cardiac Myosins Myosin Heavy Chains Myosin Subfragments Myosin Light Chains Myocarditis Myosin Type II Myocardium Ventricular Myosins Myocytes, Cardiac Myosin Type V Heart Sarcomeres Actins Actomyosin Cardiomyopathy, Hypertrophic Myosin-Light-Chain Kinase Nonmuscle Myosin Type IIA Tissue Plasminogen Activator Myosin Type I Nonmuscle Myosin Type IIB Adenosine Triphosphatases Cardiac Output Myocardial Contraction Molecular Sequence Data Plasminogen Activator Inhibitor 1 Heart Ventricles Urokinase-Type Plasminogen Activator Rabbits Carrier Proteins Muscles Autoimmune Diseases Actin Cytoskeleton Amino Acid Sequence Myofibrils Peptide Fragments Cardiomegaly Phosphorylation Cardiomyopathy, Hypertrophic, Familial Ca(2+) Mg(2+)-ATPase Arrhythmias, Cardiac Cardiac Surgical Procedures Kinetics Chickens Calcium Rats, Inbred Lew Death, Sudden, Cardiac Molecular Motor Proteins Cardiomyopathies Base Sequence Protein Binding Protein Isoforms Cells, Cultured Smooth Muscle Myosins Adenosine Triphosphate Cardiomyopathy, Dilated Myosin Type III Tropomyosin Troponin I Mutation Time Factors Binding Sites Troponin RNA, Messenger Electrophoresis, Polyacrylamide Gel Rheumatic Heart Disease Heterocyclic Compounds with 4 or More Rings Gizzard Disease Models, Animal Swine Skeletal Muscle Myosins Propylthiouracil Receptors, Urokinase Plasminogen Activator Adrenergic beta-2 Receptor Antagonists Muscle Contraction Plasminogen Activators Mice, Transgenic Autoantibodies Dogs Heart Failure Cardiac Tamponade Cardiac Pacing, Artificial Myosin-Light-Chain Phosphatase Heart Diseases G(M2) Activator Protein Promoter Regions, Genetic Gene Expression Regulation Heart Atria Recombinant Proteins Hyperthyroidism Adenosine Diphosphate Isoenzymes Echocardiography Cross Reactions Muscle, Smooth Cardiac Catheterization Ventricular Function, Left Cattle Myocardial Infarction Animals, Newborn

No FAQ available that match "investigational cardiac myosin activator"